Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease
Clinical trial NCT02528799 · COMPLETED
Trial details
- NCT number
- NCT02528799
- Sponsor
- ImmusanT, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-01-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.